M. Gürler Et Al. , "Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? ," 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022) , Manchester, England, pp.213, 2022
Gürler, M. Et Al. 2022. Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? . 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022) , (Manchester, England), 213.
Gürler, M., Gökcan, M. K., Yüksel, S., & Karahan, Z. C., (2022). Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? . 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022) (pp.213). Manchester, England
Gürler, Merve Et Al. "Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? ," 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022), Manchester, England, 2022
Gürler, Merve Et Al. "Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? ." 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022) , Manchester, England, pp.213, 2022
Gürler, M. Et Al. (2022) . "Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? ." 24th Annual Conference of the European Society for Clinical Virology (ESCV 2022) , Manchester, England, p.213.
@conferencepaper{conferencepaper, author={Merve Gürler Et Al. }, title={Are EBV and CMV involved in the development of squamous cell carcinoma of upper respiratory tract in the Turkish population? }, congress name={24th Annual Conference of the European Society for Clinical Virology (ESCV 2022)}, city={Manchester}, country={England}, year={2022}, pages={213} }